Barbie® Introduces First-Ever Barbie Doll with Type 1 Diabetes to Expand Representation and Inspire More Children
Barbie partnered with Breakthrough T1D (formerly JDRF) to create the bespoke doll in the brand's global Fashionistas lineup
The brand also honored two global role models and type 1 diabetes advocates, Peloton instructor Robin Arzón and model Lila Moss, with their own one-of-a-kind Barbie dolls made in their likeness
Article content
EL SEGUNDO, Calif. — Mattel, Inc. (NASDAQ: MAT) announced today that Barbie® is debuting the first Barbie doll with type 1 diabetes (T1D). This addition to the line enables more children to see themselves reflected in Barbie and encourages doll play that extends beyond a child's own lived experience, thereby fostering a greater sense of inclusion and empathy – all pillars of the Barbie brand's mission.
Article content
'Introducing a Barbie doll with type 1 diabetes marks an important step in our commitment to inclusivity and representation,' said Krista Berger, Senior Vice President of Barbie and Global Head of Dolls. 'Barbie helps shape children's early perceptions of the world, and by reflecting medical conditions like T1D, we ensure more kids can see themselves in the stories they imagine and the dolls they love.'
To ensure the doll design truly captures the community, Barbie partnered with Breakthrough T1D (formerly JDRF), the leading global type 1 diabetes research and advocacy organization committed to accelerating life-changing breakthroughs to cure, prevent, and treat type 1 diabetes and its complications. T1D is a chronic autoimmune condition that causes the pancreas to make very little insulin or none at all, leading to dependence on insulin therapy and the risk of short and or long-term complications. Barbie worked closely with Breakthrough T1D to accurately reflect the medical equipment those with this condition may utilize and the doll's look, all the way down to the dress pattern:
Article content
Continuous Glucose Monitor (CGM): The doll wears a CGM on her arm to help manage her type 1 diabetes. CGMs are small, wearable devices that continuously measure a person's blood-sugar levels. To keep her CGM in place, she uses heart-shaped medical tape – Barbie pink, of course – along with a phone that displays a CGM app to help track her blood sugar levels throughout the day.
Insulin Pump: Barbie has an insulin pump, a small, wearable medical device that allows for automated insulin dosing as needed, attached to her waist.
Blue Polka Dot Outfit: The doll wears a stylish polka dot top and matching skirt with ruffles. Both the color blue and circle print are nods to the global symbols that represent diabetes awareness.
Purse: The doll comes with a pastel blue purse, perfect for Barbie to carry any essentials, such as type 1 diabetes supplies or snacks, when she's on the go.
Article content
'We were thrilled when Barbie approached us to collaborate on the development of the Barbie doll with type 1 diabetes,' said Aaron J. Kowalski, Ph.D., CEO of Breakthrough T1D. 'I have lived with T1D since I was 13, and my brother since he was 3, so this partnership is deeply personal – it means the world to be part of bringing greater visibility to a condition that affects so many families. It's an honor to work with a brand that shares our commitment to showing children that a life with type 1 diabetes can be full, vibrant, and empowering.'
In continued partnership with Breakthrough T1D, Barbie donated dolls to the Breakthrough T1D 2025 Children's Congress. The biennial event, July 7-9, brings 170 children living with type 1 diabetes, ages 4-17, to Washington, DC, to meet face-to-face with members of Congress. The youth delegates travel to the nation's capital from all 50 states and Breakthrough T1D's international affiliates in the United Kingdom, Australia, Israel, the Netherlands, and Canada.
Article content
Barbie also honored two global role models and type 1 diabetes advocates – Peloton Instructor Robin Arzón in the US and model Lila Moss in the UK – with their own one-of-a-kind Barbie dolls. Arzón unveiled the new Barbie doll with type 1 diabetes and her one-of-a-kind Barbie doll at Peloton Studios NY on July 8th. Attendees and Members of the type 1 diabetes community were delighted to experience this first-of-its-kind unveiling moment.
Article content
'After being diagnosed with type 1 diabetes a decade ago, I've found a lot of purpose in advocating for people with the condition and educating others about it because knowledge is power – especially for young minds,' said Arzón. 'It's an absolute honor to receive a Barbie doll as a part of the brand's efforts to grow awareness and representation surrounding type 1 diabetes, so that we can help show kids that all types of challenges give us all the more reason to push forward and achieve our dreams.'
Article content
Lila Moss says, 'I am proud to use my platform to educate around type 1 diabetes and show that being different is cool. Receiving messages from people who see my patches and feel represented means everything to me. To be able to now see Barbie dolls with T1D, and to receive a Barbie doll that visibly looks like me even wearing her patches, is both surreal and special.'
Article content
The Barbie Fashionistas line features more than 175 looks across various skin tones, eye colors, hair colors and textures, body types, disabilities, and fashion styles, including a Blind Barbie doll, a Barbie doll with Down Syndrome, and a Barbie doll with Hearing Aids, among others. In 2020, Barbie kicked off a multi-year study with researchers at Cardiff University on the short-term and long-term benefits of doll play. It has been found that doll play serves an incredible purpose during key developmental stages, as it may help set children on a course for success by fostering empathy and developing social skills needed to excel, all while imagining their futures on an equal playing field.
Article content
The 2025 Barbie Fashionistas dolls commit to a minimum of 50% ISCC-Certified bio-circular plastic (Mass Balance Approach), with all boxes made from FSC-certified materials. By incorporating ISCC-certified plastic into these dolls, Barbie aims to reduce reliance on fossil-based materials in support of a more circular economy.
Article content
The 2025 Barbie Fashionistas dolls, including the Barbie doll with Type 1 diabetes, are now available on Mattel Shop and at retailers nationwide.
Article content
About Mattel
Article content
Mattel is a leading global toy and family entertainment company and owner of one of the most iconic brand portfolios in the world. We engage consumers and fans through our franchise brands, including Barbie®, Hot Wheels®, Fisher-Price®, American Girl®, Thomas & Friends™, UNO®, Masters of the Universe®, Matchbox®, Monster High®, MEGA® and Polly Pocket®, as well as other popular properties that we own or license in partnership with global entertainment companies. Our offerings include toys, content, consumer products, digital and live experiences. Our products are sold in collaboration with the world's leading retail and ecommerce companies. Since its founding in 1945, Mattel is proud to be a trusted partner in empowering generations to explore the wonder of childhood and reach their full potential. Visit us at mattel.com
Article content
As the leading global type 1 diabetes (T1D) research and advocacy organization, Breakthrough T1D (formerly JDRF) helps make everyday life with type 1 diabetes better while driving toward cures. We do this by investing in the most promising research, advocating for progress by working with government to address issues that impact the T1D community, and helping educate and empower individuals facing this condition.
Article content
About Type 1 Diabetes (T1D)
Article content
T1D is an autoimmune condition that causes the pancreas to make very little insulin or none at all. This leads to dependence on insulin therapy and the risk of short and long-term complications, which can include highs and lows in blood sugar; damage to the kidneys, eyes, nerves, and heart; and even death. Globally, it impacts nearly 9 million people. Many believe T1D is only diagnosed in childhood and adolescence, but diagnosis in adulthood is common and accounts for nearly 50% of all T1D diagnoses. The onset of T1D has nothing to do with diet or lifestyle. While its causes are not yet entirely understood, scientists believe that both genetic factors and environmental triggers are involved. There is currently no cure for T1D.
Article content
Article content
Article content
Article content
Article content
Contacts
Article content
News Media
Article content
Article content
Devin Duff
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
an hour ago
- Globe and Mail
2 Ultra-High-Yield Dividend Stocks at 10-Year Lows to Buy in July
Key Points The packaged food industry is facing its largest downturn in over a decade. Consumers are seeking alternatives amid growing health concerns and lifestyle changes. Conagra Brands and Campbell's have become too cheap to ignore. 10 stocks we like better than Conagra Brands › Packaged food giants Conagra Brands (NYSE: CAG) and The Campbell's Company (NASDAQ: CPB) are both down more than 25% year to date and are hovering around their lowest levels in over a decade. Both companies are industry giants. Conagra owns brands like Orville Redenbacher's, Slim Jim, Boom Chicka Pop, Hunt's, Reddi-Wip, Marie Callender's, and more. In addition to its flagship soup line, Campbell's also owns a variety of pasta sauce and dip brands, as well as snacks like Pepperidge Farm, Kettle, Cape Cod, Snyder's of Hanover, Lance, Goldfish, and more. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » Conagra and Campbell's stocks are so beaten down that they yield 6.8% and 5.1%, respectively. Here's why the sell-off in both high-yield dividend stocks is a buying opportunity for patient investors. A severe slowdown The packaged food industry has faced numerous challenges in recent years. Most recently, pullbacks in consumer spending and inflation have pressured consumer goods companies -- but the downturn is particularly bad for packaged food names. Packaged food companies are facing macroeconomic headwinds and changes in consumer behavior. A shift away from processed and packaged foods toward healthier options presents a significant challenge for the industry. Especially from companies that sell frozen and processed meals rather than just snacks and beverages. The Trump administration established the Make America Healthy Again Commission to address U.S. health concerns. In April, the U.S. Department of Health and Human Services and U.S. Food and Drug Administration announced measures to phase out all petroleum-based synthetic dyes and replace them with natural ingredients. On June 25, Conagra announced that it would remove Food, Drug & Cosmetic (FD&C) colors from its U.S. frozen product portfolio by the end of 2025. The company also stated that it will not offer products with FD&C colors sold to K-12 schools beginning with the 2026 through 2027 school year and will discontinue the manufacturing of products with FD&C colors in its U.S. retail portfolio by 2027. Conagra's peers, like General Mills, Kraft Heinz, and others, made similar announcements in June. The regulatory pressure throws a wrench in an already challenging operating environment for the industry, but it could be a net positive in the long run. Acquisition remorse In addition to macro challenges and paradigm shifts in the industry, some packaged food companies have also been dealing with the aftermath of bad acquisitions. In 2018, Conagra bought Pinnacle Foods for $10.9 billion -- a disastrous move in hindsight, given the market cap of Conagra at the time of this writing is just $9.7 billion. That same year, Campbell's bought Snyder's-Lance for $6.1 billion -- making the company a major player in the snack category through chips, pretzels, popcorn, nuts, and cookies. Campbell's then bought Sovos Brands for $2.7 billion in March 2024 to diversify its product lineup through pasta sauces, dry pasta, frozen entrees, frozen pizza, yogurt, and more soup varieties. The acquisition isn't terrible, as it opens the door to more premium brands. But it did add debt to Campbell's balance sheet. Having to manage a larger interest expense makes it even harder for the company to navigate industrywide challenges. Combined, those two acquisitions cost Campbell's $8.8 billion, nearly as much as its market cap at the time of this writing of $9.2 billion. Like Conagra, Campbell's overpaid for these brands in hindsight. Conagra's and Campbell's revenues have steadily climbed over the past few years, but that's mainly due to acquisitions -- not organic growth. Meanwhile, operating margins have significantly fallen due to weakening demand. CAG Revenue (TTM) data by YCharts In response to the poor results, both stocks are now at their lowest levels in over a decade, which has boosted their dividend yields to their highest levels in that period. CAG Dividend Yield data by YCharts Two high-yield stocks at attractive valuations As bad as Conagra's and Campbell's results have been, both companies remain impeccable cash cows. Conagra's free cash flow (FCF) per share is $3.02 compared to its $1.40 dividend per share, while Campbell's has $2.41 in FCF per share compared to a dividend per share of $1.52. So although both companies are experiencing weakening balance sheets, at least they can still support their dividends with cash from the business. In terms of valuations, both stocks are dirt cheap -- with Campbell's sporting a 12.8 price-to-FCF and 10.5 forward price-to-earnings (P/E) ratio compared to just a 6.8 price-to-FCF ratio for Conagra and an 8.3 forward P/E. For context, Campbell's 10-year median price-to-FCF ratio is 15.8 and Conagra's is 16.3 -- illustrating just how severely discounted these stocks are compared to their historical averages. Conagra and Campbell's have fallen far enough Conagra and Campbell's have been hit with a four-pronged punch of self-inflicted poor decision-making, shifts in consumer behavior, macro challenges, and regulatory changes. However, both stocks are dirt cheap and generate plenty of cash to support their high dividends. Conagra reports earnings on July 10, which will give investors a better idea of where the company is headed and the impact of changes to its food ingredients and additives. At their lowest levels in over a decade, now is a good time for income investors to scoop up shares of Conagra and Campbell's despite both stocks being heavily out of favor. Should you invest $1,000 in Conagra Brands right now? Before you buy stock in Conagra Brands, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Conagra Brands wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $695,481!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $969,935!* Now, it's worth noting Stock Advisor 's total average return is1,053% — a market-crushing outperformance compared to179%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 7, 2025 Daniel Foelber has no position in any of the stocks mentioned. The Motley Fool recommends Campbell's and Kraft Heinz. The Motley Fool has a disclosure policy.
CTV News
2 hours ago
- CTV News
Study: health of U.S. children deteriorating
Winnipeg Watch A new study looking at the overall health of U.S. Children leads MedicalWatch for July 8, 2025.
CBC
3 hours ago
- CBC
Wait for help during mental health emergency too long: outreach group
A Winnipeg volunteer outreach group says police and paramedics need to reconsider how they deal with mental health emergencies, after they say a woman in the midst of a crisis waited hours for medical attention.
